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Chronic Fatigue Syndrome (CFS) or Myalgic Encephalomyelitis (ME) is a debilitating 
disorder, affecting at least 250,000 people in the UK. Marked by debilitating fatigue, 
its aetiology is poorly understood and diagnosis controversial. A number of 
symptoms overlap with other illnesses with the result that CFS/ME is commonly 
misdiagnosed. It is important therefore that significant clinical features are 
investigated. People diagnosed with CFS/ME consistently report that they experience 
vision-related symptoms associated with their illness1-3 with some of these reports 
being verified experimentally4. Although vision-related symptoms may represent a 
significant clinical feature of CFS/ME that could be useful in its diagnosis, they have 
yet to be included in clinical guidelines.  
 
A recently developed, standardised measure designed to assess core CFS/ME 
symptoms, The DePaul Symptom Questionnaire (DSQ)5, includes 4 vision-related 
items: eye pain, sensitivity to bright lights, unable to focus vision and/or attention, 
loss of depth perception. For each item, respondents rate the symptom frequency 
along with the associated severity/bother on a 5-point scale. Here, we report DSQ 
vision-related item responses for 59 individuals (39 females, 20 males) who, after 
completing the DSQ, met its criteria for diagnosis of CFS/ME. Respondents ranged 
in age from 22-69 years (mean = 46 years; SD = 11). All reported that they had no 
history of eye disease. Responses on each item revealed that vision-related 
problems were frequently experienced, the most frequent being sensitivity to bright 
lights (92%) followed by being unable to focus vision and/or attention (88%) and eye 
pain (86%). Loss of depth perception (61%) was least frequent. The more frequent 
the symptom, the greater the apparent severity/bother (Figure 1).  
We explored each set of 4 items (Frequency and Severity) to consider whether they 
could be used to provide overall frequency and severity assessments of vision-
related symptoms. Such a consideration would help with the standardized 
assessment and establishment of norm data relating to visual-related symptoms 
associated with ME/CFS within and across populations. We considered the factor 
structure of the frequency and severity data separately, and found that parallel 
analysis suggested 1 factor on each occasion, with all factor loadings (.34 to .83) 
above the criteria of .326. Alpha coefficients for the scales exceeded the acceptable 
criteria of  = .70; Frequency,  = .72; Severity,  = .71. Factor scores for both sets 
of items shared a correlation of r =.88, p < .001; therefore sharing 64% of the 
variance, suggesting the two measures share a very close relationship. No significant 
differences were found for the factor scores for sex (Frequency, t = -1.44, p = .155; 
Severity, t = - 1.43, p = .160), nor was there a significant correlation for age 
(frequency, r = -.04, p = .777; severity, r = -.06, p = .652).  
 
In summary, responses of individuals with CFS/ME to the visual items included in the 
DePaul Symptom Questionnaire indicated that they experienced frequent and often 
severe vision-related symptoms associated with their illness. These findings are in 
agreement with those of previous self-report studies1-3 and recent experimental 
evidence for problems related to visual attention in those with CFS/ME4. They add to 
an emerging body of evidence that vision-related symptoms represent a significant 
clinical feature of CFS/ME that may provide insights into its aetiology and prove 
useful in its diagnosis. As such, they warrant further experimental study and should 
not be overlooked by CFS/ME diagnosticians. 
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 Figure 1. CFS/ME patient responses on each visual item of the DSQ. Left panel: 
Respondents rated the frequency with which they experienced each vision-related 
symptom from ‘0: none of the time’ to ‘4: all of the time’. Right panel: Respondents 
rated the bother associated with each symptom from ‘0: symptom not present’ to ‘4: 
very severe.  
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(a) Eye pain: frequency
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(c) Sensitivity to bright lights: frequency
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(g) Loss of depth perception: frequency
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(b) Eye pain: severity
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(d) Sensitivity to bright lights: severity
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(e) Unable to focus vision and/or attention: frequency
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(h) Loss of depth perception: severity
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(f) Unable to focus vision and/or attention: severity
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Throughout the past 6 months, 
how often have you had this symptom?
Throughout the past 6 months, 
how much has this symptom bothered you?
